Global scientific leaders, AI pioneers to converge at BioAsia 2026

Hyderabad: The 23rd edition of BioAsia 2026, Asia's leading life sciences and healthcare conclave, will be held in Hyderabad on Feb 17–18, 2026. It is all set to bring together global scientific leaders, artificial intelligence (AI) pioneers, pharma and biotech industry CEOs, and policymakers.Deliberations at the conference, to be held on the theme, "TechBio Unleashed: AI, Automation & the Biology Revolution", will focus on how AI, advanced biology and intelligent manufacturing are converging to reshape the discovery, development and delivery of therapies worldwide.The conference, being held less than one month after the Telangana govt unveiled its new life sciences policy 2026–30 at the World Economic Forum in Davos, will be inaugurated by chief minister A Revanth Reddy and industries and IT minister D Sridhar Babu.BioAsia 2026 comes at a time when the state govt is actively working on its ambition to position Hyderabad among the top five life sciences hubs in the world. It will also feature a dedicated "Telangana Rising Vision 2047" session that will highlight the state's roadmap for innovation-led growth across advanced therapeutic modalities, AI-enabled R&D and next-generation biomanufacturing.The speaker line-up includes Dr Stefan Miltenyi, founder and President of Miltenyi Biotec, who will speak on next-generation biologics from discovery through scalable CMC (chemistry, manufacturing and controls). Amgen's chief scientific officer, Dr Howard Y Chang, will talk about AI-powered biology for target discovery and precision medicine, and Google DeepMind's vice president of Science, Pushmeet Kohli, will speak on foundational models and protein science breakthroughs accelerating biomedical discovery.The second day will have a plenary address by Madeleine Roach, Executive Vice President and head of business operations at Sanofi, on the company's AI-first transformation across R&D and manufacturing. Day 2 will also see a focus on the rise of life sciences global capability centres in India as innovation engines that are having significant direct impact on patients.Other speakers include Anton Groom, chief AI officer at MSD; Despina Solomonidou, EVP and global head of technical R&D at Novartis; Rashmi Kumar, SVP and CIO at Medtronic; Eamonn Warren, group vice president of manufacturing at Eli Lilly; and Badhri Srinivasan, group CEO of Unilabs.Across 9 sessions and a marquee CEO Conclave, discussions will focus on scaling innovation across science, software and supply chains, sector headwinds and growth drivers through 2030, advanced modalities, and AI's role across CRDMO and biomanufacturing.